Psychiatric-Mental Health Nurse Practitioner (PMHNP) Purple Book Practice Test

Managing benzodiazepine withdrawal safely focuses on a gradual taper using a longer-acting benzodiazepine to smooth out brain exposure and minimize withdrawal symptoms and seizure risk. Converting the current dose to an equianalgebraic long-acting agent, such as diazepam, creates steadier plasma levels compared with stopping abruptly. From there, a slow, planned dose reduction—often by small amounts every 1–2 weeks and tailored to the person’s symptoms and comorbidities—allows the nervous system to adapt without rebound anxiety, insomnia, or autonomic instability. This method reduces the danger of severe withdrawal and seizures and is generally safer and more tolerable than abrupt cessation or switching to a non-benzodiazepine that does not address dependence. Barbiturates carry higher risks of overdose and dependence and are not preferred for withdrawal management, and using an SSRI does not directly mitigate benzodiazepine withdrawal symptoms. The key is a careful, individualized taper with a long-acting agent and close monitoring.